in the presence of SA11, P. multiseries increases expression of genes associated with photosynthesis and carbon fixation, presumably to support the higher growth rates observed, as well as to provide organic carbon exudates for the bacterial partner.
But the emerging picture of a diatombacterium partnership is more complex than this simple resource swap. Amin et al. postulate that the exchanges between these free-living microbes are coordinated through cycling of the hormone indole-3-acetic acid (IAA) and the amino acid tryptophan. Best known for its use by terrestrial plants to direct developmental processes such as the growth of new shoots, IAA also has a role in signalling between soil bacteria and plants 4 . The researchers demonstrate that P. multiseries and Sulfitobacter SA11 secrete tryptophan and IAA, respectively. Moreover, they show that addition of synthetic IAA to cultures of P. multiseries stimulates the diatom's growth, but that the effect is significantly greater when the IAA-producing bacterium itself is present. This indicates that, although IAA promotes diatom cell division, additional unidentified factors are involved in the positive feedback loop that results in major diatom growth enhancement. The authors also detected IAA in water samples from five North Pacific sites and present transcriptomic evidence from field samples for multiple IAA biosynthesis pathways, each incorporating different precursor molecules. Thus, it seems that IAA signalling occurs across domains of life in both the terrestrial and marine biospheres and is probably an ancient mechanism of organismal communication.
Amin and colleagues' study represents a substantial step forward for understanding the complex network of interactions between phytoplankton and bacteria and provides a springboard for development of hypotheses on cross-talk between marine microbes. For example, the extreme interaction specificity observed suggests that the consortium of bacteria residing in a particular habitat may be a major force in structuring the local phytoplankton community, or vice versa. Moreover, it seems reasonable to speculate that, in addition to IAA and tryptophan, other signalling molecules participate in inter-or intradomain communication among marine microbes.
Perhaps the most pressing question we are left with is when and where such interactions occur. Symbioses between diatoms and nitrogen-gas-fixing cyanobacteria are known 11 , and bacterial attachment to diatoms is often reported during algal blooms and in the bloom senescence phase 12, 13 . For decades, scientists have also speculated on the potential influence of microscale variability of resources in marine environments 14 and on the significance of the phycosphere 15 -a zone around algal cells considered analogous to the root zone of plants. Concentrations of algal secreted compounds are much higher in the phycosphere than in nearby sea water, owing to the basic physics of the diffusive boundary layer surrounding the cell, thus promoting growth of bacteria in this layer 13, 15 . Amin and colleagues' results suggest that the specific growth-enhancing interactions observed occur in the phycosphere, but the sampling methods and quantitation techniques needed to directly assess the physical nature of these associations are still lacking. Exciting times are ahead as scientists develop techniques to examine the physical intricacies of these mutualistic relationships, their prevalence and structuring roles in marine microbial communities, and how they might shift under environmental change. ■ This article was published online on 27 May 2015.
DEVELOPMENTAL BIOLOGY

Diversity in the lymphatic vasculature
Two studies of the cells that give rise to lymphatic vessels reveal that precursors arise from unexpected sources, demonstrating that the origins of this vasculature are more diverse than anticipated. See Articles p.56 & p.62
he lymphatic vasculature is a specialized network that drains fluid from tissues and enables immune-cell trafficking and surveillance throughout the body. This major constituent of the circulatory system was long considered to be ancillary to the blood vasculature, and as such has received less attention than its counterpart. As a result, although the roles of lymphatic vessels in tissue main tenance and disease are now well appreciated 1, 2 , their origins have remained contentious for more than a century 3, 4 . Two studies 5, 6 in this issue provide insights into the origins of the lymphatic vasculature.
In vertebrate embryos, lymphatic vessels arise from two pre-existing veins 7 . Vascular endothelial cells that line the walls of these cardinal veins turn on genes that direct venous cells to become lymphatic endothelial cells (LECs), which leave the veins and form the lymphatic vessels. In this way, one vascular network gives rise to another. But precisely how and when a pool of LEC precursors is established in the cardinal veins, and whether all cells in the early veins are identical, has remained unclear.
Zebrafish embryos are transparent, which makes them an ideal organism for visualizing cell movements. Nicenboim et al. 5 (page 56) traced early LEC development in zebrafish and unexpectedly discovered that the cells on the dorsal (upper) and ventral (lower) walls of the cardinal veins are different. The researchers report that lymphatic precursors sprout from the dorsal wall, but that these cells actually originate in the ventral wall at an earlier developmental stage (Fig. 1) .
By using fluorescence to track single cells, the authors found that precursor cells in the ventral wall divide, after which one of the two daughter cells migrates to the dorsal wall. These dorsal daughter cells can then give rise to LECs. Interestingly, the cells in the ventral wall also contribute to the intestinal blood vasculature, indicating that they can give rise to multiple types of endothelium. Nicenboim and colleagues showed that the fate of these nascent precursor cells is controlled by a signalling molecule, Wnt5b, which acts from tissues adjacent to the ventral wall of the vein. This observation points to an unexpected instructive role for ventral tissues and Wnt signalling in driving cells to become LECs.
It is difficult to pinpoint the stage at which a cell becomes committed to its future identity, but Nicenboim and colleagues' observations should prompt us to revise our thinking about how cellular identity is acquired in vascular lineages. Their work suggests that changes in cellular identity are probably coupled to dynamic cell movements, rather than to stepwise changes in gene expression, as current dogma suggests. One attractive idea is that the range of cell types that undifferentiated precursors in the vasculature can become is restricted progressively at sequential locations during vessel development. Future analyses should test this and other models.
Klotz et al. 6 (page 62) examined a later stage of development, when lymphatic vessels form in the heart, which, like all organs, uses the lymphatic system to maintain normal fluid levels and for immune-cell trafficking 8 . An understanding of how lymphatic vessels develop in individual organs, however, has been even more enigmatic than a definition of the origins of the system as a whole. Indeed, although the cardiac lymphatic system has previously been described 9 , its development, origins and functions have remained unclear.
These authors found that most of the cardiac lymphatic system in mice arises from embryonic veins located outside the heart. But unexpectedly, they show that many coronary LECs do not originate from veins at all (Fig. 1) . By using various genetic 'fate-mapping' techniques to indelibly label cells, allowing cell movements and descendants to be traced, the authors observed that roughly 20% of LECs in the heart's lymphatic vasculature originate in the yolk sac that surrounds the developing embryo. The researchers suggest that these yolk-sac cells have a previously unappreciated potential to give rise to LECs directly, in addition to their known roles in forming blood cells and vascular endothelial cells.
All fate-mapping experiments in mice must be interpreted cautiously, because the techniques used to label cells genetically can also label other cell types. Nonetheless, Klotz and colleagues' work indicates that cardiac LECs originate from different places: embryonic veins and at least one other source. Future studies that do not use genetic labelling should further clarify the origins of cardiac and other LECs in developing organs.
Klotz et al. also investigated the role of cardiac lymphatic vessels in repairing the heart after a heart attack. They found that the injuries sustained from a heart attack in mice stimulate the growth of new lymphatic vessels, which in turn promote cardiac repair. These are previously unknown functions for coronary lymphatic vessels, and the authors' findings have implications for the treatment of cardiac conditions such as heart attack and atherosclerosis. They raise the possibility that the activation of LECs in the heart may be a way to promote cardiac repair.
These two studies provide fresh insight into our vascular drainage network. Taken together, they describe an early source of LEC precursors in embryonic cardinal veins, reveal an unexpected level of diversity in the signals that control early LEC development, and demonstrate that more cell types than previously appreciated contribute to the formation of cardiac lymphatic vessels. In the light of these observations, the molecular and cellular processes that control lymphatic-vessel formation seem to be much more diverse than was previously thought. 5 report that LEC precursors from the ventral side of embryonic veins divide, before one of the two daughter cells migrates to the dorsal side of the vein. From there, these cells can differentiate into LECs and migrate to the site of forming lymphatic vessels. Klotz et al. 6 found that the LECs that form lymphatic vessels in the heart originate both from embryonic veins and from other non-venous sources, including the yolk sac.
CANCER
Precise control of localized signals
The tumour-suppressor protein PTEN is mostly found in the cell cytoplasm, tethered to endosome vesicles. This localization regulates the enzyme's activity towards specific lipids and influences its control of cell growth.
V U K STA M B O L I C
L oss of function of the PTEN tumoursuppressor protein is a common feature of many types of human cancer, including glioblastoma and prostate, kidney, thyroid and breast tumours 1 . In addition to genetic alterations occurring in sporadic tumours, germline mutations in the gene that encodes PTEN cause the group of disorders known as PTEN hamartoma tumour syndromes, which are characterized by benign tumours throughout the body and increased incidence of breast, thyroid and brain cancers 1 . Since the
